TP53 and diabetes mellitus: Eight pathways were significantly lower in the anti-DM group than the CTR group, which included “p53 signaling pathway,” while the “Biosynthesis of type II polyketide backbone” pathway was significantly higher in the anti-DM group than the CTR group (p < 0.05) (Supplementary Figure S2B).